Loading
Arctic Therapeutics
Arctic Therapeutics focuses on identifying genetic causes of major diseases and helping develop effective treatments for patients. Arctic Therapeutics aims to mitigate major risks linked to conventional drug development through the use of bioinformatics and artificial intelligence, ultimately lowering expenses and expediting the time to market. Arctic Therapeutics' research and development efforts are spearheaded by a group of global specialists in genetics, genomics, immunology, bioinformatics, and drug development
Funding
Every round, secondary, debt facility or acquisition involving Arctic Therapeutics that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—